IDEXX Laboratories, Inc. (IDXX)
704.62
-2.03
(-0.29%)
USD |
NASDAQ |
Dec 09, 13:04
IDEXX Laboratories EPS Diluted (Quarterly): 3.404 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Zoetis, Inc. | 1.627 |
| Pfizer Inc. | 0.6197 |
| Vertex Pharmaceuticals, Inc. | 4.204 |
| Amgen, Inc. | 5.934 |
| Moderna, Inc. | -0.5128 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 274.61M |
| Revenue (Quarterly) | 1.105B |
| Total Expenses (Quarterly) | 830.63M |
| Enterprise Value | 57.33B |
| Gross Profit Margin (Quarterly) | 62.01% |
| Profit Margin (Quarterly) | 24.85% |
| Earnings Yield | 1.79% |
| Operating Earnings Yield | 2.28% |
| Normalized Earnings Yield | 1.788 |